|
Accession number;04A0344798
|
| Title;Experience in Using New Viscoelastic Substance Healon V |
| Author;
MATSUSHIMA MINAKO
(Pakubyoin Ganka)
EHIRA YUKARI
(Pakubyoin Ganka)
SATO MARI
(Pakubyoin Ganka)
ARAI CHIFUYU
(Pakubyoin Ganka)
KITAZAWA YOSHIHIRO
(Pakubyoin Ganka)
|
Journal Title;Journal of the Eye
|
Journal Code:Y0754A
|
ISSN:0910-1810
|
|
VOL.21;NO.4;PAGE.531-534(2004)
|
| Figure&Table&Reference;FIG.2, REF.12 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;We used Healon V in a number of cases in which we expected difficulty in continuous curvilinear capsulorrhexis (CCC) with phacoemulsification and aspiration (PEA). We compared the number of endothelial cells, intraocular pressure and visual acuity before and after surgery. This study comprised 12 shallow anterior chamber eyes of (12 patients), 7 eyes with mydriatic defect (6 patients) and 2 eyes with hypermature cataract (2 patients). CCC was performed without Healon V leakage from the wound entrance in all cases; postoperative visual acuity was better than preoperative level in all cases. In only 1 eye, intraocular pressure increased to 25.3mmHg on the first postoperative day, but fell to 11.5mmHg without manipulation on the second postoperative day. Intraocular pressure decreased from preoperative level in all cases by the seventh postoperative day. Endothelial cell loss was 3.8%. Healon V is thought to maintain anterior chamber depth and protect endothelial cells, leading to enhanced safety in cataract surgery. (author abst.) |
|
|
|
Related Articles;
|
